Emerging synthetic cannabinoids detected by a drug checking service in Toronto, Canada.

Background: Toronto's Drug Checking Service (DCS) provides people who use drugs with information on the chemical composition of their substances and conducts real-time monitoring of the unregulated drug supply. Presented are first known data of three newly detected synthetic cannabinoids (SCs) in Toronto, Ontario.

Methods: The present data are from samples analyzed between April and November 2020.

Diverse psychotropic substances detected in drug and drug administration equipment samples submitted to drug checking services in Toronto, Ontario, Canada, October 2019-April 2020.

Background: The overdose crisis has generated innovative harm reduction and drug market monitoring strategies. In Toronto, Ontario, Canada, a multi-site drug checking service (DCS) pilot project was launched in October 2019. The project provides people who use drugs with information on the chemical composition of their substances, thereby increasing their capacity to make more informed decisions about their drug use and avoid overdose.

Drug checking services for people who use drugs: a systematic review.

Background And Aims: Drug checking services provide people who use drugs with chemical analysis results of their drug samples while simultaneously monitoring the unregulated drug market. We sought to identify and synthesize literature on the following domains: (a) the influence of drug checking services on the behaviour of people who use drugs; (b) monitoring of drug markets by drug checking services; and (c) outcomes related to models of drug checking services.

Methods: Systematic review.

Using a Capability Oriented Methodology to Build Your Cloud Ecosystem.

Organizations often struggle to capture the necessary functional capabilities for each cloud-based solution adopted for their information systems. Identifying, defining, selecting, and prioritizing these functional capabilities and the security components that implement and enforce them is surprisingly challenging. This article explains recent developments by the National Institute of Standards and Technology (NIST) in addressing these challenges.

Use of quality index tracking to drive improvement in clinical outcomes.

DAVITA QUALITY INDEX (DQI) is a scoring index that allows DaVita facilities to evaluate various aspects of patient clinical outcomes. This index was developed by DaVita Inc., the managing company of the Richmond Kidney Center.